BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Clinical Outcome
1260 results:

  • 1. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
    Fu W; Feng Q; Tao R
    Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
    Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [
    Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
    J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
    Zhang H; Tian L; Wang X; Shi X
    Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Machine learning developed a CD8
    Chen R; Zheng Y; Fei C; Ye J; Fei H
    Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Developing a novel image marker to predict the clinical outcome of neoadjuvant chemotherapy (NACT) for ovarian cancer patients.
    Zhang K; Abdoli N; Gilley P; Sadri Y; Chen X; Thai TC; Dockery L; Moore K; Mannel RS; Qiu Y
    Comput Biol Med; 2024 Apr; 172():108240. PubMed ID: 38460312
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
    Lippert J; Smith G; Appenzeller S; Landwehr LS; Prete A; Steinhauer S; Asia M; Urlaub H; Elhassan YS; Kircher S; Arlt W; Fassnacht M; Altieri B; Ronchi CL
    Eur J Endocrinol; 2024 Mar; 190(3):234-247. PubMed ID: 38451242
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
    Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
    JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and clinical outcome in Pancreatic cancer.
    Blise KE; Sivagnanam S; Betts CB; Betre K; Kirchberger N; Tate BJ; Furth EE; Dias Costa A; Nowak JA; Wolpin BM; Vonderheide RH; Goecks J; Coussens LM; Byrne KT
    Cancer Immunol Res; 2024 May; 12(5):544-558. PubMed ID: 38381401
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
    Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Locally advanced pancreatic cancer: Is surgical palliation associated with improved clinical outcome relative to medical palliation?
    Kramer SP; Tonelli C; Luchette FA; Swanson J; Abdelsattar Z; Cohn T; Baker MS
    Am J Surg; 2024 Apr; 230():73-77. PubMed ID: 38350746
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of a mobile health intervention based on multi-theory model of health behavior change on self-management in patients with differentiated thyroid cancer: protocol for a randomized controlled trial.
    Jiang Y; Sun X; Jiang M; Min H; Wang J; Fu X; Qi J; Yu Z; Zhu X; Wu Y
    Front Public Health; 2024; 12():1327442. PubMed ID: 38282759
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
    Schadeck J; Oberg HH; Peipp M; Hedemann N; Schamel WW; Bauerschlag D; Wesch D
    Front Immunol; 2023; 14():1286097. PubMed ID: 38259448
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and clinical outcome of Ovarian cancer Patients.
    Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predictive and prognostic biomarkers in urological tumours.
    Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
    Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma.
    Koskela H; Li Y; Joutsiniemi T; Muranen T; Isoviita VM; Huhtinen K; Micoli G; Lavikka K; Marchi G; Hietanen S; Virtanen A; Hautaniemi S; Oikkonen J; Hynninen J
    Gynecol Oncol; 2024 Jan; 180():91-98. PubMed ID: 38061276
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y; Gong P; Su L; Zhang M
    Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 63.